| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1468-3083.2010.03656.X |
| P698 | PubMed publication ID | 20384692 |
| P50 | author | Christopher Griffiths | Q42620963 |
| P2093 | author name string | W Sterry | |
| A Menter | |||
| International Psoriasis Council | |||
| P W Tebbey | |||
| E J Horn | |||
| P2860 | cites work | Dysfunctional blood and target tissue CD4+CD25high regulatory T cells in psoriasis: mechanism underlying unrestrained pathogenic effector T cell proliferation | Q33993967 |
| P433 | issue | 12 | |
| P921 | main subject | circulatory system | Q11068 |
| P304 | page(s) | 1371-1377 | |
| P577 | publication date | 2010-12-01 | |
| P1433 | published in | Journal of the European Academy of Dermatology and Venereology | Q15760872 |
| P1476 | title | Exploring the association between cardiovascular and other disease-related risk factors in the psoriasis population: the need for increased understanding across the medical community | |
| P478 | volume | 24 |
| Q37892623 | A tale of two plaques: convergent mechanisms of T-cell-mediated inflammation in psoriasis and atherosclerosis |
| Q55177498 | Association between Vitamin D deficiency and psoriasis: An exploratory study. |
| Q42367098 | Association of Metabolic Syndrome in Chronic Plaque Psoriasis Patients and their Correlation with Disease Severity, Duration and Age: A Case Control Study from Western Maharashtra |
| Q40069191 | Cardiometabolic Disorders in Psoriatic Disease |
| Q38076496 | Cardiovascular aspects of psoriasis: an updated review |
| Q35564655 | Cardiovascular comorbiditiy in psoriasis |
| Q44398860 | Cardiovascular disease event rates in patients with severe psoriasis treated with systemic anti-inflammatory drugs: a Danish real-world cohort study |
| Q53749532 | Factors influencing cardiometabolic risk profile in patients with psoriasis. |
| Q40571559 | GlycA Is a Novel Biomarker of Inflammation and Subclinical Cardiovascular Disease in Psoriasis. |
| Q37621976 | Impaired heart rate recovery indices in psoriasis patients |
| Q38651883 | Kidney disease and psoriasis: novel evidences beyond old concepts. |
| Q37961072 | Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement |
| Q36897095 | Metabolic syndrome in patients with psoriatic disease. |
| Q37846678 | New interleukin-23 pathway inhibitors in dermatology: ustekinumab, briakinumab, and secukinumab |
| Q37874647 | Obesity and the skin. |
| Q28730205 | Pharmacological undertreatment of coronary risk factors in patients with psoriasis: observational study of the Danish nationwide registries |
| Q52319510 | Psoriasis and Cardiovascular Diseases: A Literature Review to Determine the Causal Relationship. |
| Q48245405 | Psoriasis and comorbidities in a southern Brazilian population: a case-control study |
| Q40419030 | Psoriasis: Epidemiology, clinical features, co-morbidities, and clinical scoring |
| Q37553636 | Relationship between psoriasis and non-alcoholic fatty liver disease |
| Q58549759 | Skin Autofluorescence, as a Measure of AGE Accumulation in Individuals Suffering from Chronic Plaque Psoriasis |
Search more.